Selinexor in Combination with Cladribine, Cytarabine and G-CSF for Relapsed or Refractory AML

被引：0
|
作者：
Uy, Geoffrey L.
Rettig, Michael P.
Fletcher, Theresa
Riedell, Peter A.
Stockerl-Goldstein, Keith E.
Ghobadi, Armin
Jacoby, Meagan
Cashen, Amanda F.
Romee, Rizwan
Pusic, Iskra
Abboud, Camille N.
Schroeder, Mark A.
Vij, Ravi
Westervelt, Peter
DiPersio, John F.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
816
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PRIMING REGIMENTS BASED ON IDARUBICIN, OR ACLACINOMYCIN OR PIRARUBICIN COMBINING WITH CYTARABINE AND G-CSF FOR REINDUCTION OF REFRACTORY/ RELAPSED ALL
    Zhu, J.
    Miao, Y.
    Zhang, Y.
    Zhu, Y.
    Zhu, H.
    Wu, Z.
    He, G.
    Li, J.
    HAEMATOLOGICA, 2016, 101 : 663 - 664
  • [22] G-CSF priming in AML
    Buechner, T.
    Berdel, W. E.
    Haferlach, T.
    Schoch, C.
    Ludwig, W. -D.
    Serve, H.
    Kienast, J.
    Staib, P.
    Grueneisen, A.
    Lengfelder, E.
    Hehlmann, R.
    Kern, W.
    Eimermacher, H.
    Arnold, R.
    Hirschmann, W. -D.
    Hartlapp, J.
    Baldus, M.
    Reis, H. E.
    Frickhofen, N.
    Reichle, A.
    Lohrmann, H. -P.
    Weh, A. J.
    Suedhoff, T.
    Truemper, L.
    Fauser, A.
    Sauerland, M. C.
    Heinecke, A.
    Woermann, B.
    Hiddemann, W.
    ANNALS OF HEMATOLOGY, 2006, 85 : 30 - 31
  • [23] G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (GCLAM) in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Grade Myeloid Neoplasms: Final Results from a Phase 1/2 Trial
    Halpern, Anna B.
    Huebner, Emily M.
    Othus, Megan
    Scott, Bart L.
    Becker, Pamela S.
    Percival, Mary-Elizabeth M.
    Hendrie, Paul C.
    Gardner, Kelda M.
    Buckley, Sarah A.
    Estey, Elihu H.
    Walter, Roland B.
    BLOOD, 2017, 130
  • [24] Efficacy and safety of G-CSF, low-dose cytarabine and aclarubicin in combination with L-asparaginase, prednisone in the treatment of refractory or relapsed acute lymphoblastic leukemia
    Zhou, Keshu
    Song, Yongping
    Zhang, Yanli
    Wei, Xudong
    Fu, Yuewen
    Yu, Fengkuan
    Zhou, Hu
    Liu, Xinjian
    Zhou, Jian
    Fang, Baijun
    LEUKEMIA RESEARCH, 2017, 62 : 29 - 33
  • [25] FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children
    McCarthy, AJ
    Pitcher, LA
    Hann, IM
    Oakhill, A
    MEDICAL AND PEDIATRIC ONCOLOGY, 1999, 32 (06): : 411 - 415
  • [26] FLAG (fludarabine, high-dose cytarabine and G-CSF) for refractory and high-risk relapsed acute leukemia in children
    Sarper, N
    Yalman, N
    MEDICAL AND PEDIATRIC ONCOLOGY, 2000, 34 (02): : 163 - 163
  • [27] The role of G-CSF combination in conditioning regimen for CBT patients with AML
    Takahashi, S.
    Ooi, J.
    Kato, S.
    Kawakita, T.
    Nakauchi, Y.
    Monna, M.
    Nagamura, T.
    Kato, K.
    Yamaguchi, T.
    Asano, S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S123 - S123
  • [28] Efficacy and safety of stem cell mobilization with etoposide plus cytarabine plus G-CSF in poor mobilizers with relapsed or refractory lymphoma
    Zhu, Zhijuan
    Li, Xiaofan
    Yuan, Xiaohong
    Chen, Xianling
    Lin, Ting
    Guo, Xiangli
    Li, Nainong
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [29] Phase I Trial of Clofarabine and High Dose Cytarabine with G-CSF Priming (G-CLAC) for Relapsed or Refractory Acute Myeloid Leukemia
    Becker, Pamela S.
    Estey, Elihu
    Petersdorf, Stephen
    Hendrie, Paul C.
    Pagel, John M.
    Stirewalt, Derek
    Shustov, Andrei
    Storer, Barry E.
    Appelbaum, Frederick R.
    BLOOD, 2008, 112 (11) : 1018 - 1018
  • [30] Randomized trial of GM-CSF and G-CSF following high-dose cytarabine and mitoxantrone chemotherapy for relapsed and refractory acute leukemia.
    Baer, Maria R.
    Ford, Laurie A.
    Bundy, Brian N.
    Tighe, Sheila M.
    O'Loughlin, Kieran L.
    Slack, James L.
    Wetzler, Meir
    Wallace, Paul K.
    BLOOD, 2006, 108 (11) : 223B - 223B
12345